-
公开(公告)号：US20240150456A1
公开(公告)日：2024-05-09
申请号：US18282696
申请日：2022-04-02
发明人： Fei XU , Ruidong Hao , Wang Zhang , Shu Wu
IPC分类号： C07K16/28 , A61K39/00 , A61P35/00 , C07K14/705 , C07K14/71 , C12N5/0783
CPC分类号： C07K16/28 , A61K39/4631 , A61K39/4637 , A61K39/464402 , A61P35/00 , C07K14/70521 , C07K14/71 , C12N5/0636 , C07K2319/03 , C12N2510/00
摘要： The present disclosure provides immune effector cells engineered to express a functional exogenous receptor such as a CAR armored with a tumor homing peptide. The immune effector cells according to the present disclosure have enhanced tumor infiltration and anti-tumor efficacy.
-
公开(公告)号：US11958903B2
公开(公告)日：2024-04-16
申请号：US17043054
申请日：2019-03-29
发明人： Wang Zhang , Shuai Yang , Shu Wu , Chuan-Chu Chou
CPC分类号： C07K16/2803 , A61P35/00 , C07K16/2818 , A61K2039/505 , C07K2317/24 , C07K2317/31 , C07K2317/33 , C07K2317/569 , C07K2317/92
摘要： The present application provides anti-LAG-3 constructs comprising a single-domain antibody (sdAb) that specifically recognizes LAG-3. Also provided are methods of making and using these constructs.
-
公开(公告)号：US20230136252A1
公开(公告)日：2023-05-04
申请号：US17910608
申请日：2021-03-12
发明人： Wang Zhang , Jintao Guo , Fengyuan TANG , Shuai Yang , Yuanyuan Peng , An Tang , Xiaojie Tu , Yunlei Liu , Shu Wu
IPC分类号： C07K16/30 , C12N5/0783 , C07K14/725 , C07K14/705 , C07K16/18 , C07K14/54 , A61K35/17 , A61K39/395 , A61K38/17 , A61K38/20 , A61K31/454 , A61P35/00 , A61P25/00 , A61P11/00
摘要： The present application provides GPC2-specific antibodies and antigen binding fragments thereof. A chimeric antigen receptor (CAR) that specifically binds glypican-2 (GPC2) comprising a GPC2-specific antibody, a transmembrane domain, and an intracellular signaling domain. T cells comprising the disclosed CAR constructs can be used for cancer immunotherapy.
-
公开(公告)号：US11905327B2
公开(公告)日：2024-02-20
申请号：US16958397
申请日：2018-12-28
发明人： Wang Zhang , Shu Wu , Shuai Yang , Qi Pan , Chuan-Chu Chou
IPC分类号： C07K16/02 , A61K39/395 , A61P35/00 , C07K16/28 , A61K39/00
CPC分类号： C07K16/2803 , A61P35/00 , C07K16/2818 , C07K16/2827 , A61K2039/505 , C07K2317/22 , C07K2317/24 , C07K2317/31 , C07K2317/33 , C07K2317/569 , C07K2317/76 , C07K2317/92 , C07K2317/94
摘要： Provided are constructs comprising a single-domain antibody (sdAb) moiety that specifically recognizes TIGIT. Also provided are methods of making and using these constructs.
-
公开(公告)号：US20220249563A1
公开(公告)日：2022-08-11
申请号：US17618642
申请日：2020-07-17
发明人： Tao Zhao , Yuanyuan Peng , An Tang , Sujuan Wang , Shuai Yang , Wang Zhang , Shu Wu , Ruidong Hao
IPC分类号： A61K35/17 , C07K16/18 , C07K14/725 , C07K14/705 , C07K14/71 , A61P35/00 , C12N5/0783
摘要： Provided herein are anti-DLL3 chimeric antigen receptors (CARs), DLL3 binding proteins and uses of such CARs or DLL3 binding proteins in the treatment of DLL3 associated disorders, such as small cell lung cancer.
-
公开(公告)号：US20240041924A1
公开(公告)日：2024-02-08
申请号：US18026297
申请日：2021-09-29
发明人： Fengyuan TANG , Wang Zhang , Yuanyuan Peng , Zhongsheng HU , Shu Wu
CPC分类号： A61K35/17 , C12N5/0636 , C07K16/2833 , C07K16/242 , C07K16/2878 , C07K16/2851 , A61K39/4611 , A61K39/4631 , A61K39/464417 , A61P35/00 , A61K2239/13
摘要： A polypeptide comprising a chimeric antigen receptor (CAR) comprising (i) an extracellular domain capable of binding to a first antigen, (ii) a transmembrane domain, and (iii) an intracellular domain; and a domain capable of binding to a second antigen expressed on the surface of a cell that can interact with a T cell, wherein the CAR and the domain are fused by a peptide linker.
-
公开(公告)号：US20220265709A1
公开(公告)日：2022-08-25
申请号：US17251310
申请日：2019-06-19
发明人： Huihui Zhang , Fangliang Zhang , Tao Zhao , Ming Zeng , Yafeng Zhang , Wang Zhang , Shu WU , Qi Pan , Shuai Yang
摘要： A system for inducing activity of immune cells, comprises a chimeric antigen receptor, a T cell receptor, and various combinations thereof.
-
公开(公告)号：US20210017279A1
公开(公告)日：2021-01-21
申请号：US17043054
申请日：2019-03-29
发明人： Wang Zhang , Shuai YANG , Shu WU , Chuan-Chu CHOU
摘要： The present application provides anti-LAG-3 constructs comprising a single-domain antibody (sdAb) that specifically recognizes LAG-3. Also provided are methods of making and using these constructs.
-
-
-
-
-
-
-
搜索结果
8 条记录 (耗时 0.014 秒)
